PRGS and in-situ immunophenotype as a combined „tool“ for monitoring
the therapeutical efficiency of PIPAC in different peritoneal
cancer diseases: a single centre experience.

Daniel Neureiter; Eckhard Klieser; Bettina Neumayer; Ricarda Gruber; JP Ramspott; Philipp Schredl; Klaus Emmanuel; Tarkan Jäger

PRGS and in-situ immunophenotype as a combined „tool“ for monitoring the therapeutical efficiency of PIPAC in different peritoneal cancer diseases: a single centre experience.

Daniel Neureiter, Eckhard Klieser, Bettina Neumayer, Ricarda Gruber, JP Ramspott, Philipp Schredl, Klaus Emmanuel, Tarkan Jäger

Publikation: Konferenzbeitrag › Abstrakt

Originalsprache	Englisch
Publikationsstatus	Veröffentlicht - 2021
Veranstaltung	33rd European Congress of Pathology - Gothenburg, Schweden Dauer: 29 Aug. 2021 → 31 Aug. 2021

Konferenz mit wissenschaftlichem Inhalt

Konferenz mit wissenschaftlichem Inhalt	33rd European Congress of Pathology
Land/Gebiet	Schweden
Ort	Gothenburg
Zeitraum	29/08/21 → 31/08/21

1 Poster

PRGS and in-situ immunophenotype as a combined „tool“ for monitoring the therapeutical efficiency of PIPAC in different peritoneal cancer diseases: a single centre experience.
Neureiter, D., Klieser, E., Neumayer, B., Gruber, R., Ramspott, J., Schredl, P., Emmanuel, K. & Jäger, T., 2021.
Publikation: Konferenzbeitrag › Poster

Dieses zitieren

@conference{3419c56cd20b4c8e8685328827a2f004,

title = "PRGS and in-situ immunophenotype as a combined „tool“ for monitoring the therapeutical efficiency of PIPAC in different peritoneal cancer diseases: a single centre experience.",

author = "Daniel Neureiter and Eckhard Klieser and Bettina Neumayer and Ricarda Gruber and JP Ramspott and Philipp Schredl and Klaus Emmanuel and Tarkan J{\"a}ger",

year = "2021",

language = "English",

note = "33rd European Congress of Pathology ; Conference date: 29-08-2021 Through 31-08-2021",

}

TY - CONF

T1 - PRGS and in-situ immunophenotype as a combined „tool“ for monitoring the therapeutical efficiency of PIPAC in different peritoneal cancer diseases: a single centre experience.

AU - Neureiter, Daniel

AU - Klieser, Eckhard

AU - Neumayer, Bettina

AU - Gruber, Ricarda

AU - Ramspott, JP

AU - Schredl, Philipp

AU - Emmanuel, Klaus

AU - Jäger, Tarkan

PY - 2021

Y1 - 2021

M3 - Abstract

T2 - 33rd European Congress of Pathology

Y2 - 29 August 2021 through 31 August 2021

ER -

PRGS and in-situ immunophenotype as a combined „tool“ for monitoring the therapeutical efficiency of PIPAC in different peritoneal cancer diseases: a single centre experience.

Konferenz mit wissenschaftlichem Inhalt

Publikationen

PRGS and in-situ immunophenotype as a combined „tool“ for monitoring the therapeutical efficiency of PIPAC in different peritoneal cancer diseases: a single centre experience.

Dieses zitieren